G6PT Inhibition Model Using HL-60 Cells and Induction of ROS Production Through PKC/NOX2 Activation: Clinical Condition for Elucidation of Glycogen Storage Disease Type Ib
Biological and Pharmaceutical Bulletin - Japan
doi 10.1248/bpb.b13-00708
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Pharmaceutical Society of Japan